{"id":334195,"date":"2026-10-31T21:11:54","date_gmt":"2026-10-31T15:41:54","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/rainbow-children-s-medicare-q2-results-fy27-pat-84-crore\/"},"modified":"2026-10-31T21:11:54","modified_gmt":"2026-10-31T15:41:54","slug":"rainbow-children-s-medicare-q2-results-fy27-pat-84-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/rainbow-children-s-medicare-q2-results-fy27-pat-84-crore\/","title":{"rendered":"Rainbow Children&#8217;s Medicare Q2 Results FY27: Profit Rises 10.94% as Revenue Hits Rs 548.02 Cr, PAT Rs 83.89 Cr"},"content":{"rendered":"<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">Rainbow Children&#8217;s Medicare Q2 Results FY27 were declared on 31 October 2026 for the July to September 2026 quarter. Consolidated revenue rose 23.21% year on year to Rs 548.02 Cr, while net profit rose 10.94% to Rs 83.89 Cr. These quarterly results show YoY growth in every line, with Operating Profit at Rs 169.98 Cr, up 14.19% from Rs 148.86 Cr.<\/p>\n<\/div>\n<p><a href=\"https:\/\/univest.in\/stocks\/rainbow\/rainbow-children's-medicare-ltd-share-price-today\">Rainbow Children&#8217;s Medicare Ltd<\/a> (RAINBOW) Q2 Results FY27 announced on 31 October 2026, covering the company&#8217;s financial performance for the July to September quarter. Rainbow Children&#8217;s Medicare Q2 Results FY27 carry a results date of 31 October 2026 and present consolidated results, with revenue of Rs 548.02 Cr and net profit (PAT) of Rs 83.89 Cr.<\/p>\n<p>This results analysis of Rainbow Children&#8217;s Medicare Q2 Results covers the financial highlights, business factors, outlook and risks for the quarter. It starts with the Financial Highlights table that sets out revenue, Operating Profit and net profit against the same quarter last year.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=quarterly_results\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/rainbow-children-s-medicare-q2-results-fy27-pat-84-crore\/#Rainbow_Childrens_Medicare_Q2_Results_FY27_Financial_Highlights\" title=\"Rainbow Children&#8217;s Medicare Q2 Results FY27: Financial Highlights\">Rainbow Children&#8217;s Medicare Q2 Results FY27: Financial Highlights<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/rainbow-children-s-medicare-q2-results-fy27-pat-84-crore\/#Key_Takeaways_from_Rainbow_Childrens_Medicare_Q2_Results_What_Stands_Out\" title=\"Key Takeaways from Rainbow Children&#8217;s Medicare Q2 Results: What Stands Out\">Key Takeaways from Rainbow Children&#8217;s Medicare Q2 Results: What Stands Out<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/rainbow-children-s-medicare-q2-results-fy27-pat-84-crore\/#Rainbow_Childrens_Medicare_Q2_Results_FY27_Performance_Analysis\" title=\"Rainbow Children&#8217;s Medicare Q2 Results FY27: Performance Analysis\">Rainbow Children&#8217;s Medicare Q2 Results FY27: Performance Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/rainbow-children-s-medicare-q2-results-fy27-pat-84-crore\/#Key_Business_Factors_This_Quarter\" title=\"Key Business Factors This Quarter\">Key Business Factors This Quarter<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/rainbow-children-s-medicare-q2-results-fy27-pat-84-crore\/#FY27_Outlook_After_Rainbow_Childrens_Medicare_Q2_Results\" title=\"FY27 Outlook After Rainbow Children&#8217;s Medicare Q2 Results\">FY27 Outlook After Rainbow Children&#8217;s Medicare Q2 Results<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/rainbow-children-s-medicare-q2-results-fy27-pat-84-crore\/#Key_Risks_to_Watch_After_Rainbow_Childrens_Medicare_Q2_Results_FY27\" title=\"Key Risks to Watch After Rainbow Children&#8217;s Medicare Q2 Results FY27\">Key Risks to Watch After Rainbow Children&#8217;s Medicare Q2 Results FY27<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/rainbow-children-s-medicare-q2-results-fy27-pat-84-crore\/#Narrower_Net_Profit_Margin\" title=\"Narrower Net Profit Margin\">Narrower Net Profit Margin<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/rainbow-children-s-medicare-q2-results-fy27-pat-84-crore\/#Lower_Return_on_Capital_Employed\" title=\"Lower Return on Capital Employed\">Lower Return on Capital Employed<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/rainbow-children-s-medicare-q2-results-fy27-pat-84-crore\/#Profit_Growing_Slower_Than_Sales\" title=\"Profit Growing Slower Than Sales\">Profit Growing Slower Than Sales<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/rainbow-children-s-medicare-q2-results-fy27-pat-84-crore\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/rainbow-children-s-medicare-q2-results-fy27-pat-84-crore\/#Frequently_Asked_Questions_on_Rainbow_Childrens_Medicare_Q2_Results_FY27\" title=\"Frequently Asked Questions on Rainbow Children&#8217;s Medicare Q2 Results FY27\">Frequently Asked Questions on Rainbow Children&#8217;s Medicare Q2 Results FY27<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/rainbow-children-s-medicare-q2-results-fy27-pat-84-crore\/#What_are_Rainbow_Childrens_Medicare_Q2_Results_FY27\" title=\"What are Rainbow Children&#8217;s Medicare Q2 Results FY27?\">What are Rainbow Children&#8217;s Medicare Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/rainbow-children-s-medicare-q2-results-fy27-pat-84-crore\/#What_is_the_results_date_for_Rainbow_Childrens_Medicare_Q2_Results_FY27\" title=\"What is the results date for Rainbow Children&#8217;s Medicare Q2 Results FY27?\">What is the results date for Rainbow Children&#8217;s Medicare Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/rainbow-children-s-medicare-q2-results-fy27-pat-84-crore\/#What_revenue_was_reported_in_Rainbow_Childrens_Medicare_Q2_Results_FY27\" title=\"What revenue was reported in Rainbow Children&#8217;s Medicare Q2 Results FY27?\">What revenue was reported in Rainbow Children&#8217;s Medicare Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/rainbow-children-s-medicare-q2-results-fy27-pat-84-crore\/#What_net_profit_was_reported_in_Rainbow_Childrens_Medicare_Q2_Results_FY27\" title=\"What net profit was reported in Rainbow Children&#8217;s Medicare Q2 Results FY27?\">What net profit was reported in Rainbow Children&#8217;s Medicare Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/rainbow-children-s-medicare-q2-results-fy27-pat-84-crore\/#How_much_YoY_growth_did_revenue_show_in_Rainbow_Childrens_Medicare_Q2_Results_FY27\" title=\"How much YoY growth did revenue show in Rainbow Children&#8217;s Medicare Q2 Results FY27?\">How much YoY growth did revenue show in Rainbow Children&#8217;s Medicare Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/rainbow-children-s-medicare-q2-results-fy27-pat-84-crore\/#Did_net_profit_rise_or_fall_in_Rainbow_Childrens_Medicare_Q2_Results\" title=\"Did net profit rise or fall in Rainbow Children&#8217;s Medicare Q2 Results?\">Did net profit rise or fall in Rainbow Children&#8217;s Medicare Q2 Results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/rainbow-children-s-medicare-q2-results-fy27-pat-84-crore\/#What_was_the_Operating_Profit_in_Rainbow_Childrens_Medicare_Q2_Results_FY27\" title=\"What was the Operating Profit in Rainbow Children&#8217;s Medicare Q2 Results FY27?\">What was the Operating Profit in Rainbow Children&#8217;s Medicare Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/rainbow-children-s-medicare-q2-results-fy27-pat-84-crore\/#Are_Rainbow_Childrens_Medicare_Q2_Results_consolidated_results_or_standalone_results\" title=\"Are Rainbow Children&#8217;s Medicare Q2 Results consolidated results or standalone results?\">Are Rainbow Children&#8217;s Medicare Q2 Results consolidated results or standalone results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/rainbow-children-s-medicare-q2-results-fy27-pat-84-crore\/#What_business_factors_shaped_Rainbow_Childrens_Medicare_Q2_Results_FY27\" title=\"What business factors shaped Rainbow Children&#8217;s Medicare Q2 Results FY27?\">What business factors shaped Rainbow Children&#8217;s Medicare Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/rainbow-children-s-medicare-q2-results-fy27-pat-84-crore\/#What_are_the_key_risks_after_Rainbow_Childrens_Medicare_Q2_Results_FY27\" title=\"What are the key risks after Rainbow Children&#8217;s Medicare Q2 Results FY27?\">What are the key risks after Rainbow Children&#8217;s Medicare Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/univest.in\/blogs-2\/rainbow-children-s-medicare-q2-results-fy27-pat-84-crore\/#What_is_the_outlook_after_Rainbow_Childrens_Medicare_Q2_Results\" title=\"What is the outlook after Rainbow Children&#8217;s Medicare Q2 Results?\">What is the outlook after Rainbow Children&#8217;s Medicare Q2 Results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-23\" href=\"https:\/\/univest.in\/blogs-2\/rainbow-children-s-medicare-q2-results-fy27-pat-84-crore\/#Where_can_I_find_the_complete_Rainbow_Childrens_Medicare_Q2_Results_FY27_data\" title=\"Where can I find the complete Rainbow Children&#8217;s Medicare Q2 Results FY27 data?\">Where can I find the complete Rainbow Children&#8217;s Medicare Q2 Results FY27 data?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Rainbow_Childrens_Medicare_Q2_Results_FY27_Financial_Highlights\"><\/span><strong>Rainbow Children&#8217;s Medicare Q2 Results FY27: Financial Highlights<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<tbody>\n<tr>\n<th>Metric<\/th>\n<th>Q2 FY27 (Sep 26)<\/th>\n<th>Q2 FY26 (Sep 25)<\/th>\n<th>YoY Change<\/th>\n<\/tr>\n<tr>\n<td><strong>Revenue<\/strong><\/td>\n<td>Rs 548.02 Cr<\/td>\n<td>Rs 444.8 Cr<\/td>\n<td>+23.21% YoY<\/td>\n<\/tr>\n<tr>\n<td><strong>Operating Profit<\/strong><\/td>\n<td>Rs 169.98 Cr<\/td>\n<td>Rs 148.86 Cr<\/td>\n<td>+14.19% YoY<\/td>\n<\/tr>\n<tr>\n<td><strong>Net Profit (PAT)<\/strong><\/td>\n<td>Rs 83.89 Cr<\/td>\n<td>Rs 75.62 Cr<\/td>\n<td>+10.94% YoY<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Source: company filing for Rainbow Children&#8217;s Medicare Q2 Results FY27, 31 October 2026. Figures in Rs Crore, Consolidated basis.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Takeaways_from_Rainbow_Childrens_Medicare_Q2_Results_What_Stands_Out\"><\/span><strong>Key Takeaways from Rainbow Children&#8217;s Medicare Q2 Results: What Stands Out<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Revenue:<\/strong> Revenue rose 23.21% year on year to Rs 548.02 Cr from Rs 444.80 Cr in the same quarter last year.<\/li>\n<li><strong>Net profit:<\/strong> Net profit (PAT) rose 10.94% to Rs 83.89 Cr from Rs 75.62 Cr, a slower pace than the revenue line.<\/li>\n<li><strong>Operating Profit:<\/strong> Operating Profit reached Rs 169.98 Cr, up 14.19% from Rs 148.86 Cr, sitting between revenue and net profit growth.<\/li>\n<li><strong>Margin watch:<\/strong> Net profit margin narrowed to 15.3% from 17.0% in the comparison quarter, the main risk headline for this filing.<\/li>\n<li><strong>Next step:<\/strong> Positive YoY growth in all three lines sets up the Rainbow Children&#8217;s Medicare Q2 Results FY27 performance analysis that follows.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Rainbow_Childrens_Medicare_Q2_Results_FY27_Performance_Analysis\"><\/span><strong>Rainbow Children&#8217;s Medicare Q2 Results FY27: Performance Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The performance analysis shows that Rainbow Children&#8217;s Medicare Q2 Results FY27 delivered consolidated revenue of Rs 548.02 Cr, up 23.21% from Rs 444.80 Cr a year earlier. Operating Profit grew 14.19% to Rs 169.98 Cr and net profit grew 10.94% to Rs 83.89 Cr, so the quarterly results show higher figures across all three lines.<\/p>\n<p>Growth was strongest at the revenue line at 23.21%, followed by Operating Profit at 14.19% and net profit at 10.94%. This ordering means the Rainbow Children&#8217;s Medicare Q2 Results results analysis points to a smaller share of each rupee of sales reaching profit than a year earlier, with net profit margin at 15.3% against 17.0%.<\/p>\n<p>Revenue has also risen in each of the last 4 quarters, a pattern investors can track in the next filing. The consolidated figures for July to September 2026 now form the base for Rainbow Children&#8217;s Medicare Q2 Results FY27 comparisons, and the business factors behind these numbers come next.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check the Univest Screener for live results data<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Business_Factors_This_Quarter\"><\/span><strong>Key Business Factors This Quarter<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><strong>Revenue Growth<\/strong> &#8211; The business factors begin with revenue, which grew 23.2% year on year to Rs 548.02 Cr in the latest quarter. These quarterly results show the top line moving ahead of both profit lines reported with Rainbow Children&#8217;s Medicare Q2 Results FY27.<\/p>\n<p><strong>Consecutive Quarterly Gains<\/strong> &#8211; Revenue has risen in each of the last 4 quarters, so the Rs 548.02 Cr reported this time extends a run of consecutive increases. The figures confirm the run but do not establish the specific cause.<\/p>\n<p><strong>Return on Equity<\/strong> &#8211; Return on equity was 18.10% in FY26. Net profit also rose 10.9% year on year to Rs 83.89 Cr this quarter, so the longer profitability measure and the latest earnings can be read side by side.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"FY27_Outlook_After_Rainbow_Childrens_Medicare_Q2_Results\"><\/span><strong>FY27 Outlook After Rainbow Children&#8217;s Medicare Q2 Results<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>FY27 full-year results will depend on the quarters that follow and on disclosed sector conditions. Net profit of Rs 83.89 Cr and Operating Profit of Rs 169.98 Cr give a reference point for those later comparisons, and revenue of Rs 548.02 Cr sets the quarterly base.<\/p>\n<p>Readers following this results analysis can use the Univest Screener and the Univest app to compare later filings after Rainbow Children&#8217;s Medicare Q2 Results FY27 against the next quarter&#8217;s net profit and revenue. The next set of figures will show whether the margin move persists, which brings the discussion to the risks.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_to_Watch_After_Rainbow_Childrens_Medicare_Q2_Results_FY27\"><\/span><strong>Key Risks to Watch After Rainbow Children&#8217;s Medicare Q2 Results FY27<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Narrower_Net_Profit_Margin\"><\/span><strong>Narrower Net Profit Margin<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Net profit margin narrowed to 15.3% from 17.0% in the comparison quarter. The YoY growth in net profit of 10.94% trailed revenue growth of 23.21%, which makes the margin the first figure to watch in the next filing.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Lower_Return_on_Capital_Employed\"><\/span><strong>Lower Return on Capital Employed<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Return on capital employed declined to 28.25% in FY26 from 29.83% in FY25. Investors tracking Rainbow Children&#8217;s Medicare Q2 Results FY27 may want to see whether the ratio holds in later disclosures as the company reports further quarters.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Profit_Growing_Slower_Than_Sales\"><\/span><strong>Profit Growing Slower Than Sales<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Net profit grew 10.9% against revenue growth of 23.2%, so less of each rupee of sales reached the bottom line. The gap between the two growth rates is a measurable item to compare quarter by quarter.<\/p>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track quarterly results as they are declared.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Rainbow Children&#8217;s Medicare Q2 Results FY27 record revenue of Rs 548.02 Cr and net profit of Rs 83.89 Cr, both higher year on year. These consolidated results and the other quarterly results figures in this article are best read with the margin data alongside. For Rainbow Children&#8217;s Medicare Q2 Results readers, consulting a SEBI-registered advisor before acting on any figure is advisable.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice. Research Analyst: Uniresearch Global Pvt. Ltd., SEBI Registration No. INH000013776.<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_on_Rainbow_Childrens_Medicare_Q2_Results_FY27\"><\/span><strong>Frequently Asked Questions on Rainbow Children&#8217;s Medicare Q2 Results FY27<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_are_Rainbow_Childrens_Medicare_Q2_Results_FY27\"><\/span><strong>What are Rainbow Children&#8217;s Medicare Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Rainbow Children&#8217;s Medicare Q2 Results FY27 cover the July to September 2026 quarter on a consolidated basis. Alongside this, revenue came in at Rs 548.02 Cr and net profit at Rs 83.89 Cr, as the Quick Answer shows.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_results_date_for_Rainbow_Childrens_Medicare_Q2_Results_FY27\"><\/span><strong>What is the results date for Rainbow Children&#8217;s Medicare Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The results date for Rainbow Children&#8217;s Medicare Q2 Results FY27 is 31 October 2026, covering the July to September 2026 quarter. This matches the opening section, which also states the consolidated results basis used for every figure.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_revenue_was_reported_in_Rainbow_Childrens_Medicare_Q2_Results_FY27\"><\/span><strong>What revenue was reported in Rainbow Children&#8217;s Medicare Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Rainbow Children&#8217;s Medicare reported Q2 FY27 consolidated revenue of Rs 548.02 Cr, compared with Rs 444.80 Cr a year earlier. That comparison sits in the Financial Highlights table and drives the Performance Analysis section.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_net_profit_was_reported_in_Rainbow_Childrens_Medicare_Q2_Results_FY27\"><\/span><strong>What net profit was reported in Rainbow Children&#8217;s Medicare Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Rainbow Children&#8217;s Medicare reported Q2 FY27 net profit of Rs 83.89 Cr against Rs 75.62 Cr a year earlier. This net profit appears in the Financial Highlights table, while the Performance Analysis compares it with revenue.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_much_YoY_growth_did_revenue_show_in_Rainbow_Childrens_Medicare_Q2_Results_FY27\"><\/span><strong>How much YoY growth did revenue show in Rainbow Children&#8217;s Medicare Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue showed YoY growth of 23.21% in Rainbow Children&#8217;s Medicare Q2 Results FY27, moving from Rs 444.80 Cr to Rs 548.02 Cr. This is the fastest of the three growth rates, as the Performance Analysis section explains.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Did_net_profit_rise_or_fall_in_Rainbow_Childrens_Medicare_Q2_Results\"><\/span><strong>Did net profit rise or fall in Rainbow Children&#8217;s Medicare Q2 Results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Net profit rose in Rainbow Children&#8217;s Medicare Q2 Results, up 10.94% from Rs 75.62 Cr to Rs 83.89 Cr. That rise was slower than the 23.21% revenue growth, so the Key Takeaways section highlights the gap.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_was_the_Operating_Profit_in_Rainbow_Childrens_Medicare_Q2_Results_FY27\"><\/span><strong>What was the Operating Profit in Rainbow Children&#8217;s Medicare Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Operating Profit in Rainbow Children&#8217;s Medicare Q2 Results FY27 was Rs 169.98 Cr, up 14.19% from Rs 148.86 Cr a year earlier. This places it between revenue growth and net profit growth, as the Key Takeaways section notes.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Are_Rainbow_Childrens_Medicare_Q2_Results_consolidated_results_or_standalone_results\"><\/span><strong>Are Rainbow Children&#8217;s Medicare Q2 Results consolidated results or standalone results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Rainbow Children&#8217;s Medicare Q2 Results are consolidated results, so the figures reflect the group rather than a single entity. The opening section and the Financial Highlights table both apply this consolidated basis to every metric.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_business_factors_shaped_Rainbow_Childrens_Medicare_Q2_Results_FY27\"><\/span><strong>What business factors shaped Rainbow Children&#8217;s Medicare Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue growth of 23.2% year on year, four straight quarters of rising revenue and return on equity of 18.10% in FY26 shaped Rainbow Children&#8217;s Medicare Q2 Results FY27. The Key Business Factors section lists each of them.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_key_risks_after_Rainbow_Childrens_Medicare_Q2_Results_FY27\"><\/span><strong>What are the key risks after Rainbow Children&#8217;s Medicare Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> After Rainbow Children&#8217;s Medicare Q2 Results FY27, the risks are a net profit margin of 15.3% against 17.0%, return on capital employed of 28.25% against 29.83%, and profit growing slower than sales. The Key Risks section covers each.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_outlook_after_Rainbow_Childrens_Medicare_Q2_Results\"><\/span><strong>What is the outlook after Rainbow Children&#8217;s Medicare Q2 Results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The FY27 outlook after Rainbow Children&#8217;s Medicare Q2 Results depends on later quarters and disclosed sector conditions. The Outlook section treats net profit of Rs 83.89 Cr and revenue of Rs 548.02 Cr as the reference base.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Where_can_I_find_the_complete_Rainbow_Childrens_Medicare_Q2_Results_FY27_data\"><\/span><strong>Where can I find the complete Rainbow Children&#8217;s Medicare Q2 Results FY27 data?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The complete Rainbow Children&#8217;s Medicare Q2 Results FY27 data is in the Financial Highlights table above, with revenue, Operating Profit and net profit for both periods. Readers can use the Univest Screener alongside it to compare future quarters.<\/p>\n<p><script type=\"application\/ld+json\" class=\"faq-schema\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What are Rainbow Children's Medicare Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Rainbow Children's Medicare Q2 Results FY27 cover the July to September 2026 quarter on a consolidated basis. Alongside this, revenue came in at Rs 548.02 Cr and net profit at Rs 83.89 Cr, as the Quick Answer shows.\"}},{\"@type\":\"Question\",\"name\":\"What is the results date for Rainbow Children's Medicare Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The results date for Rainbow Children's Medicare Q2 Results FY27 is 31 October 2026, covering the July to September 2026 quarter. This matches the opening section, which also states the consolidated results basis used for every figure.\"}},{\"@type\":\"Question\",\"name\":\"What revenue was reported in Rainbow Children's Medicare Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Rainbow Children's Medicare reported Q2 FY27 consolidated revenue of Rs 548.02 Cr, compared with Rs 444.80 Cr a year earlier. That comparison sits in the Financial Highlights table and drives the Performance Analysis section.\"}},{\"@type\":\"Question\",\"name\":\"What net profit was reported in Rainbow Children's Medicare Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Rainbow Children's Medicare reported Q2 FY27 net profit of Rs 83.89 Cr against Rs 75.62 Cr a year earlier. This net profit appears in the Financial Highlights table, while the Performance Analysis compares it with revenue.\"}},{\"@type\":\"Question\",\"name\":\"How much YoY growth did revenue show in Rainbow Children's Medicare Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue showed YoY growth of 23.21% in Rainbow Children's Medicare Q2 Results FY27, moving from Rs 444.80 Cr to Rs 548.02 Cr. This is the fastest of the three growth rates, as the Performance Analysis section explains.\"}},{\"@type\":\"Question\",\"name\":\"Did net profit rise or fall in Rainbow Children's Medicare Q2 Results?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Net profit rose in Rainbow Children's Medicare Q2 Results, up 10.94% from Rs 75.62 Cr to Rs 83.89 Cr. That rise was slower than the 23.21% revenue growth, so the Key Takeaways section highlights the gap.\"}},{\"@type\":\"Question\",\"name\":\"What was the Operating Profit in Rainbow Children's Medicare Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Operating Profit in Rainbow Children's Medicare Q2 Results FY27 was Rs 169.98 Cr, up 14.19% from Rs 148.86 Cr a year earlier. This places it between revenue growth and net profit growth, as the Key Takeaways section notes.\"}},{\"@type\":\"Question\",\"name\":\"Are Rainbow Children's Medicare Q2 Results consolidated results or standalone results?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Rainbow Children's Medicare Q2 Results are consolidated results, so the figures reflect the group rather than a single entity. The opening section and the Financial Highlights table both apply this consolidated basis to every metric.\"}},{\"@type\":\"Question\",\"name\":\"What business factors shaped Rainbow Children's Medicare Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue growth of 23.2% year on year, four straight quarters of rising revenue and return on equity of 18.10% in FY26 shaped Rainbow Children's Medicare Q2 Results FY27. The Key Business Factors section lists each of them.\"}},{\"@type\":\"Question\",\"name\":\"What are the key risks after Rainbow Children's Medicare Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"After Rainbow Children's Medicare Q2 Results FY27, the risks are a net profit margin of 15.3% against 17.0%, return on capital employed of 28.25% against 29.83%, and profit growing slower than sales. The Key Risks section covers each.\"}},{\"@type\":\"Question\",\"name\":\"What is the outlook after Rainbow Children's Medicare Q2 Results?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The FY27 outlook after Rainbow Children's Medicare Q2 Results depends on later quarters and disclosed sector conditions. The Outlook section treats net profit of Rs 83.89 Cr and revenue of Rs 548.02 Cr as the reference base.\"}},{\"@type\":\"Question\",\"name\":\"Where can I find the complete Rainbow Children's Medicare Q2 Results FY27 data?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The complete Rainbow Children's Medicare Q2 Results FY27 data is in the Financial Highlights table above, with revenue, Operating Profit and net profit for both periods. Readers can use the Univest Screener alongside it to compare future quarters.\"}}]}<\/script><br \/>\n<script type=\"application\/ld+json\" class=\"news-article-schema\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"NewsArticle\",\"headline\":\"Rainbow Children's Medicare Q2 Results FY27: Profit Rises 10.94% as Revenue Hits Rs 548.02 Cr, PAT Rs 83.89 Cr\",\"description\":\"Rainbow Children's Medicare Q2 Results: Consolidated revenue \u20b9548.02 Cr, PAT \u20b983.89 Cr. Check YoY growth and results analysis from the 31 October 2026 filing.\",\"author\":{\"@type\":\"Organization\",\"name\":\"Univest\"},\"publisher\":{\"@type\":\"Organization\",\"name\":\"Univest\",\"url\":\"https:\/\/univest.in\"},\"about\":{\"@type\":\"Corporation\",\"name\":\"Rainbow Children's Medicare Ltd\"}}<\/script><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Rainbow Children&#8217;s Medicare Q2 Results FY27: revenue Rs 548.02 Cr, up 23.21%, and net profit Rs 83.89 Cr, up 10.94% YoY.<\/p>\n","protected":false},"author":29,"featured_media":334194,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5331],"tags":[],"class_list":["post-334195","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-https-univest-in-blogs-category-results"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["334194"],"rank_math_title":["Rainbow Children's Medicare Q2 Results FY27: PAT Rs 83.89 Cr, Revenue Up 23.21%"],"rank_math_description":["Rainbow Children's Medicare Q2 Results: Consolidated revenue \u20b9548.02 Cr, PAT \u20b983.89 Cr. Check YoY growth and results analysis from the 31 October 2026 filing."],"rank_math_focus_keyword":["Rainbow Children's Medicare Q2 Results"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/10\/rainbow-children-s-medicare-q2-results-fy27-profit-rises-10-94-as-revenue-hits.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/334195","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=334195"}],"version-history":[{"count":0,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/334195\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/334194"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=334195"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=334195"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=334195"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}